UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024921
Receipt number R000028672
Scientific Title A Study on the skin effect by relaxation (2)
Date of disclosure of the study information 2016/12/01
Last modified on 2017/05/24 12:56:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the skin effect by relaxation (2)

Acronym

A Study on the skin effect by relaxation (2)

Scientific Title

A Study on the skin effect by relaxation (2)

Scientific Title:Acronym

A Study on the skin effect by relaxation (2)

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Dermatology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the dermatological efficacy of relaxation for healthy female face

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluation of the stratum corneum water content, the transepidermal water loss, the skin color, the skin viscoelasticity, the stratum corneum cell size, skin temperature, heart rate, salivary component and the psychological assessment after the repeated relaxation for 8week.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Relaxation is performed before every skin care for 8 weeks

Interventions/Control_2

Resting with closing eyes is performed before every skin care for 8 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

60 years-old >

Gender

Female

Key inclusion criteria

1. Healthy females aged from 40 to 59 years old.
2. After menopause
3. Person whose skin with chapping or person with dry skin.
4. Person with sensitive skin.
5. Person who have trouble about mind and body.
6. People who are interested in relaxation and have will to continue it.

Key exclusion criteria

1. Person who have abnormalities in the skin of a measured region
2. Person who are out patients.
3. Person with experience of relaxation.
4. Person who have possibilities for emerging allergy to cosmetics.
5. Persons had cosmetic surgery in the past year.
6. Person who participate in the other clinical studies within 4 weeks in the past, or person who have a schedule which participates in other clinical studies during a test period.
7. Person who are take a drug prescribed by doctor .
8. Those to whom the person himself/herself and a family are working for the cosmetics company, the food company, an advertising agency, investigation and consultant business, and a mass media-related company.
9. person with dependence on caffeine
10. Current smoker

Target sample size

45


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshinori Sugiyama

Organization

Kao Corporation

Division name

R&D Health Beauty Products Research

Zip code


Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan

TEL

03-5630-9534

Email

sugiyama.yoshinori@kao.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Mayumi Inoue

Organization

Kao Corporation

Division name

R&D Health Beauty Products Research

Zip code


Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, Japan

TEL

03-5630-9534

Homepage URL


Email

inoue.mayumi1@kao.co.jp


Sponsor or person

Institute

701 Research Inc.

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

株式会社セブンオーワンリサーチ/ Above Access(東京都)


Other administrative information

Date of disclosure of the study information

2016 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 11 Month 11 Day

Date of IRB


Anticipated trial start date

2016 Year 12 Month 08 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 11 Month 21 Day

Last modified on

2017 Year 05 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028672


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name